Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Fisogni
Unfavorable Prognostic Impact of MYC Increased Copy Number (ICN) in Patients With Diffuse Large B-Cell (DLBCL) and High-Grade Lymphoma Treated With Immunochemotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Increased MYC Gene Copy Number Correlates With Increased mRNA Levels in Diffuse Large B-Cell Lymphoma
Haematologica
Hematology
Antiviral Therapy and Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) With Hepatitis C (Hcv)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Gene Mutations and Copy Number Alterations (Cna) Predict for Early Failure in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Treated With R-Chop
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Real-World Prognostic Impact of Bcl2 and Myc Expression and Translocation Among Diffuse Large B-Cell Lymphoma Patients Treated With First-Line R-Chop
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Immunochemoradiotherapy or Immunochemotherapy Only in Patients With Extranonal Diffuse Large B-Cell Lymphoma of Stomach
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Prognostic Nomogram for Overall Survival in Patients With Diffuse Large B‐Cell Lymphoma
Oncologist
Cancer Research
Medicine
Oncology
Young High Risk Patients With Diffuse Large B-Cell Lymphoma Including BCL-2/Myc Double Hit Lymphomas Benefit From Dose-Dense Immunochemotherapy With Early CNS Prophylaxis
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Prognostic Significance of Serum Immunoglobulin Paraprotein in Patients With Diffuse Large B Cell Lymphoma
British Journal of Haematology
Hematology
Multiplex Polymerase Chain Reaction-Based Prognostic Models in Diffuse Large B-Cell Lymphoma Patients Treated With R-Chop
British Journal of Haematology
Hematology
